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ABSTRACT 
In biological fluids, hCG and its free (1. (hCGa) and d-subunits 
(hCG@), occur in multiple forms. These various forms differ at the 
molecular level primarily in glycosylation, but also differ in protein 
backbone modifications corresponding to the urinary low molecular 
weight fragment of the hCG&subunit ($-core fragment). This microh- 
eterogeneous nature can be demonstrated by isoelectric focusing in 
which variants are separated into bands with different isoelectric points 
(PI). To determine whether such isoelectric variants differ in antige- 
nicity and consequently might escape immunoassay detection due to 
overspecificity of monoclonal antibodies (MCA), urinary pregnancy 
hCG (NIH, CR123) and tumor hCG preparations, such as a tumor- 
specific acidic variant of hCG (hCGav) and the hCGD-core fragment, 
were separated by isoelectric focusing in the absence or presence of 8 
M urea, or by sodium docedyl sulfate-polyacrylamide gel electrophoresis 
A S ANY other glycoprotein hormone, hCG is composed of cr-(hCGa) and o-subunits (hCG@ noncovalently 
linked after posttranslational modifications (reviewed in 1, 
2). Physiologically, hCG is mainly a secretory product of the 
placental syncytiotrophoblast. For trophoblastic diseases, 
such as choriocarcinoma, hydatidiform mole, and nonsemi- 
nomatous testicular cancer, hCG is an established tumor 
marker (1, 3). Apart from the holo-hormone, tumors secrete 
variable quantities of free hCGm and/or hCGb (4-8). Gly- 
coprotein hormones, such as hCG, have been shown to occur 
in heterogeneous forms rather than as homogeneous molec- 
ular entities. This microheterogeneity is generally understood 
to result from posttranslational modifications. Glycosylation 
variants with varying degrees of negatively charged terminal 
sialic acids (9-11) consequently differ in their net charge (12), 
and thus in their isoelectric points (PI). 
We have developed a panel of monoclonal antibodies 
(MCA) against hCG (13), hFSH (14), bLH (15), and against 
the free subunits of hCG (4) that allowed us to determine 
the number and topographical arrangement of epitopes on 
hCG (4, 16). On this basis, we were able to construct epitope- 
selective immunoassays for the detection of holo-hCG and 
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and enzymatically immunostained using an MCA panel directed 
against 17 different hCG epitopes. MCA against 14 different epitopes 
accessible on holo-hCG recognized all pI variants of pregnancy holo- 
hCG or tumor-derived hCGav, as was true for the three MCA recogniz- 
ing epitopes hidden on holo-hCG but accessible on the free subunits 
after hCG dissociation by urea. 
We conclude that each individual pI-isoform of holo-hCG and its 
free subunits expresses the entire set of epitopes recognized by our 
MCA oanel. The carbohvdrate moieties that form a biochemical basis 
for hC’G heterogeneity seem to be neither of major antigenic relevance, 
nor are they structurally related to any particular epitope. Thus, various 
elvcosvlation forms of hCG. hCGa. hCGB. and hCG&core in normal 
as weil as in pathological samples should safely be detectable and 
measureable by immunoassays employing MCA with appropriate sub- 
unit specificity. (J C’lin Endocrinol Metab 7’7: 347-351, 1993) 
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its free subunits, respectively (4, 8). Further, we developed a 
sensitive and effective method to analyze the electrical charge 
heterogeneity of hCG by isoelectrofocusing (IEF) and im- 
munoblotting. A highly acidic variant of hCG (hCGav) was 
detected in any patient presenting with trophoblastic tumor. 
hCGav is nearly absent during normal pregnancy and there- 
fore apparently indicative for tumor-derived hCG (3, 17). 
Diagnostic immunoassays for hCG and its free subunits 
require that the antibodies employed are able to recognize 
all variants with similar affinity, or at least do not exclude 
one or several major molecular forms. Whereas overspecif- 
icity is no problem with polyclonal antisera which, a priori, 
have been raised against microheterogenous preparations of 
hCG or hCG[j it may become relevant when MCA are used 
(8). 
Since the above-mentioned hCGav can comprise up to 
45% of the total hCG content in serum (17), and, since 
hCG/%core is one of the major urinary hCG-derived com- 
ponents (18, 19), the question of their antigenic properties 
arose. The contribution of normal pregnancy-derived or 
oversized tumor hCG carbohydrate moieties to immunolog- 
ical epitopes could have major impact on the reliable detec- 
tion and measurement of tumor-derived hCG variants b! 
MCA based immunoassays. This issue may be particularly 
crucial if proportions of variants differ at certain stages of 
tumorigenesis or tumor recurrence. We therefore addressed 
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the question of whether variants of normal pregnancy hCG, 
abnormal tumor hCG, and free hCG subunits can be recog- 
nized by our MCA and thus expose all previously described 
epitopes. 
MCA 
Materials and Methods 
MCA against hCG, free hCGa, free hCGB, hFSH, and bLH were 
characterized as to affinity and subunit-specificity by one-site double 
antibody direct binding and competitive RIA and enzyme-linked im- 
munosorbent assay (ELISA) (13, 4, 14, 15). Epitope specificity was 
assessed by two-site immunoassays (4, 14, 16). Seventeen different 
epitopes can be distinguished on hCG and its subunits. The 14 epitopes 
which are accessible on holo-hCG are termed according to their subunit 
localization: cul to a5, 01 to /35, and cl to c4, the latter referring to 
‘conformational’ (c) a@ epitopes exclusively exposed by holo-hCG. 
Three epitopes, a6, /36 and 07, are present only on the nonassociated 
subunits (hidden epitopes). The 17 epitopes are recognized by the 
following 17 MCA: INN(sbruck)-hFSH-73 (epitope ol), INN-hFSH-98 
(cu2), INN-hCG-15 (013), INN-hFSH-132 (a4), INN-hFSH-158 ((u5), 
INN-hCG-72 (o6), INN-hCG-2 (/31), INN-hCG-22 (p2), INN-bLH-I 
@3), INN-hCG-24 @4), INN-hCG-58 (@5), INN-hCG-64 (p6), INN- 
hCG-68 @7), INN-hCG-10 (cl), INN-hCG-40 (c2), INN-hCG-45 (c3), 
and INN-hCG-26 (~4). 
Purification of the hCGav and of the hCGP-core fragment 
hCGav was purified, as described previously (17), from the urine of 
patient H.K., who had metastatic nonseminomatous testicular cancer. 
Urine from patient C.F., who also suffered from nonseminomatous 
testicular cancer, was concentrated in an ultrafiltration cell (Amicon 
Corporation, Lexington, Mass.) with a molecular filter YM-5 (5 kD cut 
off) and thereafter lyophilized. An aliquot of 300 rg was dissolved in 3 
mL distilled water, applied to a 2.5 X 100 cm Ultrogel AcA 44 column 
(Serva, Heidelberg, FRG) and eluted at 4 C with 30 mL/h 0.01 M Tris- 
HCl/0.15 M NaCl (pH 8.0). Marker proteins were run for mol wt 
estimation. Fractions of 9 mL were measured simultaneously by two 
immunoradiometric assays specific for holo-hCG and the free hCG@- 
subunit, respectively (7). Those fractions devoid of holo-hCG but con- 
taining low mol wt fragments with immunoreactivity for hCGB (hCGfl- 
core fraction) were pooled, concentrated, and rechromatographed as 
described above. Enriched hCG@-core was extensively dialyzed against 
ammonium bicarbonate (0.01 M) and lyophilized. Its apparent mol wt 
was 12,000. This material will be referred to as less than 12 kDa fraction, 
in contrast to the greater than 12 kDa fraction which contained holo- 
hCG and free hCG/3. 
Polyacrylnmide gel IEF 
Preparative IEF in granulated gels (pH gradient 3-6; ampholytes, 
Serva, Heidelberg, FRG) was performed according to manufacturer’s 
instructions (LKB, Bromma, Sweden). Analytical IEF (pH gradient 3-10) 
of purified hCG preparations was performed on polyacrylamide gels as 
described previously (17). Samples from patients or standard prepara- 
tions (100 ~1; l-10 mg protein/ml) were applied to polyacrylamide gels 
(size:160 x 60 X 0.5 mm) with filter paper strips (Whatman no. 1; 135 
X 3 mm) and focused: T = 7.7%, C = 3%; pH gradient 3-10; water 
cooling; constant power was set at 15 W for 90 min. 
Western blot analysis 
Proteins resolved by IEF or sodium dodecyl sulfate-polyacrylamide 
gel electrophoresis (SDS-PAGE) were electrophoretically transferred to 
nitrocellulose sheets (Biotec-Fischer, Reiskirchen, FRG) at 200 mA for 1 
h. Lanes containing the mol wt standards were then removed and 
stained with india ink. Sample lanes were treated for 5 min with sample 
buffer (0.05 M Tris-HCl/O.lS M NaC1/0.5% Tween 20/pH 10.3) and then 
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incubated in an incubation manifold for 1 h at 20 C with either of the 
17 MCA (ascites diluted 1:200 in sample buffer) against the 17 different 
hCG epitopes. After extensive washing of the shegts with sample buffer 
without Tween 20, p1 bands were detected by an alkaline phosphatase- 
conjugated antimouse immunoglobulin G F(ab), antibody (Zymed, San 
Francisco, CA; 1:500 in sample buffer, 30 min). Removal of excess 
conjugate by thorough washing was followed by addition of the sub- 
strate (5-bromo-4-chloro-3-indolyl-phosphate/nitro blue tetrazolium). 
Results 
Pregnancy hCG 
Highly purified urinary standard preparations of preg- 
nancy holo-hCG and its isolated subunits were run on SDS- 
gels, transferred to nitrocellulose sheets, and stained in par- 
allel with MCA. In these Western blots holo-hCG (NIH, 
CR123) appeared as a single band between 47 kDa and 63 
kDa, free hCGP (NIH, CR123B) between 33 kDa and 45 kDa 
and free hCGa (NIH, CR123A) between 20 kDa and 28 kDa 
(Fig. 1). These relative size differences on SDS-PAGE corre- 
spond to the different mol wt as determined by gel chroma- 
tography and other methods (2). 
Since all lanes within one blot contained equal amounts 
of antigen, differences in staining intensity between MCA 
reflected differences in MCA affinity. Staining strength dif- 
ferences between two antigen preparations (holo-hCG, free 
subunit) of a given MCA is likely due to conformational 
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FIG. 1. Analysis of highly purified standard pregnancy hCG (NIH, 
CR123), hCGa (NIH, CR123A), and hCG@ (NIH, CR123B) by SDS- 
PAGE and Western blotting. Immunostaining with 17 different MCA 
against 17 distinct epitopes of hCG and its free subunits designated cul 
to p7. Development by an antimouse immunoglobulin G-alkaline phos- 
phatase conjugate. The mol wt markers (to the right) phosphorylase b 
(94 k), BSA (67 k), ovalbumin (43 k), carbonic anhydrase (30 k), 
soybean trypsin inhibitor (20.1 k) and a-lactalbumin (14.4 k) were 
stained with India ink. Holo-hCG (upper panel), which is detected by 
MCA against public epitopes ((~1 to (~5, 01 to 85, cl to c4) appears as 
a broad single band with an apparent mol wt between 47 k and 63 k. 
Free hCGB subunit (mol wt: 33 k-45 k) stained exclusively with j3- 
MCA including the MCA directed against free hCGp (06 and 87). Free 
hCGcv (mol wt, 20 k-28 k) can be detected only with a-MCA. 
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changes of a particular epitope. An example is the MCA 
specific for the epitope al, which weakly stained holo-hCG 
but strongly reacted with the isolated a-subunit (Fig. 1). This 
phenomenon has also been observed in competitive RIA (4) 
where this MCA displayed affinities (K,) for hCG and free 
hCG& of 6.9 X 10h and 5.7 X 10’ liter/mol, respectively. 
core, a-homodimer) from hCG and free hCG-subunit stand- 
ard preparations. They were analyzed by IEF, or SDS-PAGE, 
combined with Western blotting. Similar to the standard 
preparations, both molecular forms and all pI variants could 
specifically be detected with our MCA (Figs. 3 and 4). 
IEF of holo-hCG and each of its free subunits revealed 
multiple bands with different pl (Fig. 2a). Approximate pl 
values ranged from 4 to 8 for holo-hCG, 8 to 10 for free 
hCGa, and 3 to 7 for free hCGP. Each pl isoform of the three 
standard preparations was detected by any of the respective 
MCA (Fig. 2a). In the presence of 8 M urea, holo-hCG 
dissociated completely into its subunits (Fig. 2b). 
hCGav 
The preparation of hCGav (p1 3.63 to 3.93) appeared to 
be quite homogenous (Fig. 3b) and more acidic than the most 
acidic forms within standard pregnancy hCG (Fig. 3a). 
Tumor-derived hCG 
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-urea 
hCGav (l-l K) hCG CR123 
-urea +st4 urea + at4 urea 
PH 
From the urine of two patients (H.K., CF.) with nonsem- 
inomatous testicular cancer, hCG variants were obtained that 
differed by charge (hCGav) or by size and charge (hCG@ 
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FIG. 2. Analytical IEF and Western blotting analysis of highly purified 
standard pregnancy hCG (NIH, CR123), free hCGoc (NIH, CR123A), 
and free hCGo! (NIH, CR123B). Immunostaining with 17 different 
MCA against 17 distinct epitopes of hCG. a) Antibody staining patterns 
with holo-hCG (c-MCA), free hCGa (CX-MCA), and free hCG/3 (P-MCA) 
are highly similar within each group. Thus, any major isoelectric variant 
of pregnancy hCG and of its free subunits, respectively, exposes the 
same immunological determinants. b) The isoforms of the intact a@- 
heterodimer (hCG, NIH, CR 123, left panel), detected only by MCA 
against epitopes on the surface of holo-hCG ((~4, cl, and 04), have 
isoelectric points of 4-8. Upon complete urea-dissociation of the holo- 
hormone (right panel), the free subunit-specific epitopes 016 and p7 
emerge, whereas holo-hCG-specific determinants disappear (cl). Free 
hCG subunits either display alkaline isoelectric points of above 8 
(hCGa) or acidic points of below 4.5 (hCGp). This is in accordance 
with higher numbers of terminal sialic acid residues on hCGp as 
compared to hCGa. 
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FIG. 3. IEF analysis of the highly acidic (p1 3.63-3.93) tumor-derived 
hCG variant (hCGav from patient H.K.) compared to pregnancy hCG 
(NIH, CR123). hCGav was obtained by preparative IEF and immuno- 
stained. MCA representative for each of the five main specificity groups 
are shown: the antibody directed against epitope (~4 recognizes holo- 
hCG and free (Y, 016 only free OL, cl only the intact @-dimer, fl4 holo- 
hCG, and free hCG@ and p7 only free hCGp. a) hCG (NIH, CR123) in 
the absence of urea has a p1 in the range of 4-7. b) hCGav in the 
absence of urea: highly acidic holo-hCG (cl, (~4, @4), as well as minor 
amounts of copurified acidic free subunits ((~6, @7), could be specifically 
detected by our MCA. c) hCGav in the presence of urea dissociated 
into its free subunits with either alkaline pIs (free hCGcz) or acidic pIs 
(hCGfl). d) hCG (NIH, CR123) dissociated in the presence of urea into 
its free subunits. 
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FIG. 4. SDS-PAGE (a, b) and IEF (c, d) analysis of a charge and a 
mol wt hCG variant from the urine of the patient C.F. Immunostaining 
with MCA which are representative for each of the five main antibody 
specificity groups is shown: the antibody directed against epitope (~3 
recognizes holo-hCG and free (Y, (~6 only free 01, cl only the intact qV- 
dimer, p4 holo-hCG and free hCGB and 07 only free hCG& SDS-PAGE 
(a) and IEF (c) analysis of the less than 12 kDa fraction obtained by 
Ultrogel AcA 44 filtration from urine. The MCA directed against 
epitopes 84 and p7 detected a highly basic molecule (hCG@core) with 
an apparent mol wt of 14-20 k (SDS-PAGE) corresponding to 12 k, as 
determined by gel filtration. SDS-PAGE (b) and IEF (d) analysis of 
the urinary greater than 12 kDa fraction containing molecules such as 
holo-hCG (lanes: (~3, cl, @4), free a-subunit (lane: (u3), free hCGfl 
(lanes: 04 and 07) and the 45 kDa a-homodimer (lane: ot6). 
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HCGav consisted predominantly of holo-hCG, as demon- 
strated by c-MCA. Minor amounts of free a- and fl-subunits 
were copurified (Fig. 3b). Obviously a given charge can be 
associated with molecules of vastly different sizes, such as 
holo-hCG, free hCGa or free hCG0. After complete disso- 
ciation of hCGav by 8 M urea (no staining with c-MCA), the 
pattern of cu-MCA-labeled p1 variants appeared quite similar 
to that seen with the a-subunit of dissociated pregnancy 
hCG, whereas P-MCA-stained pI isoforms were less hetero- 
geneous and generally more acidic (Fig. 3, c and Id). This 
suggests that overglycosylation or oversialylation of holo- 
hCGav had occurred on the /3- rather than the a-subunit. 
hCGB-core and a-homodimer 
Analysis of the two urinary fractions of patient CF. sep- 
arated by gel chromatography on Ultrogel AcA 44 revealed 
two further variants of hCG. The less than 12 kDa fraction 
contained hCGP-core (Fig. 4a), significantly smaller than 
standard hCG@ (see Fig. 1) and normal-sized hCGP that was 
immunodetected via epitopes 04 and /37 in the greater than 
12 kDa fraction (Fig. 4b). HCGP-core displayed a pI in the 
high alkaline region (Fig. 4c), where intact hCGP never occurs 
(Fig. 4d). Most noteworthy, in the greater than 12 kDa 
fraction the MCA highly specific for the free a-subunit ((~6) 
stained a band of much larger size than expected (Fig. 4b). 
However, this molecular variant, with an apparent size of 45 
kDa is smaller than holo-hCG stained with cl-MCA and 
with (~3-MCA (Fig. 4b). The greater than 12 kDa fraction 
also contained some free hCGa that appeared as a band of 
smaller size when stained with the a3-MCA (Fig. 4b). 
Discussion 
Since pregnancy or tumor-derived variants of holo-hCG, 
hCGa, and hCG@, often represent major fractions in body 
fluids, e.g. hCGP-core (18) and hCGav (17), can amount up 
to more than 90% and 45% of hCG immunoreactivity, 
respectively, the possibility that certain hCG forms might 
escape immunoassay detection by highly specific MCA is of 
major practical importance (17, 18, 20, 21). Variant forms of 
hCG either differ in the extent of glycosylation, the degree 
of terminal sialylation, and hence their net charge (12), or in 
their protein backbone amino acid structure (19). A main 
task of the present study was to clarify the involvement of 
oligosaccharides in epitopes expressed on hCG and their 
influences on antibody recognition in view of MCA overspe- 
cificity. After separation, either according to molecular size 
by SDS-PAGE or according to net charge by IEF, we analyzed 
in Western blots whether standard pregnancy and tumor- 
derived molecular variants of hCG and of its free subunits 
exposed the full array of epitopes recognized by our 17 
different MCA. 
The present investigation provides clear evidence that all 
MCA against the 14 different accessible epitopes of holo- 
hCG recognized all pl variants of standard pregnancy hCG 
(NIH, CR123) and tumor-derived hCG. The same was true 
for the three MCA against the three free subunit-specific 
epitopes. This suggests that the overall antigenic properties 
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of holo-hCG, hCGa, and hCG6 are preserved on physiolog- 
ical and pathological isoelectric variants. 
There are two asparagine (N)-linked oligosaccharides on 
hCGcv (Asn 52, Asn 78), two on hCGg (Asn 13, Asn 30) and 
four serine (0)linked oligosaccharides on the C-terminal 
peptide (CTP; 9, 10). Each (N)-linked carbohydrate of preg- 
nancy hCG has been described to be potentially biantennary, 
and each (0)-linked unit to be monoantennary but neverthe- 
less carrying two N-acetyl neuraminic acids (for review see 
2, 11). Thus, hCGcv carries maximum of 4 and hCGP up to 
12 sialic acid residues. Consequently, the overall net charge 
of holo-hCG is primarily determined by its P-subunit. 
Similar to holo-hCG, which carries up to 16 sialic acid 
residues, free p-subunits showed an IEF pattern covering 
most of the p1 range (3 to 10) of our system. By contrast, free 
a-subunits localized in the alkaline p1 region corresponding 
to their limited number of sialic acid residues (11). Hence, 
there is some overlap of variants of holo-hCG and free @- 
subunits, in the pI range from 5 to 7, but not of detached 
free hCGa-subunits (Fig. 2a). 
hCGav was identified as a tumor-derived variant with 
abnormally high negative surface charge predominantly lo- 
calized in its P-subunit. This isoform might be based on an 
increased terminal sialylation and in multiantennary oligo- 
saccharides (22, 23). It is not known whether hCGav repre- 
sents a translational product of physiologically silent hCGP 
genes. Urine from healthy pregnant women and from tumor 
patients contains hCG/?-core (18) a small biologically inactive 
form of hCG/3 lacking, among other sequences, the CTP (19). 
Lectin-binding studies revealed that this molecule is nearly 
devoid of sialic acid (24) which is consistent with its alkaline 
pI of greater than 8. We found that purified tumor-derived 
hCG&core could be labeled with all @MCA, including those 
directed against the hidden subunit epitopes P6 and 87. [p] 
Interestingly, some copurified material corresponded to an 
apparent size of 45 kDa in SDS-PAGE. Since this band was 
stained by the cub-MCA, which is specific for the free CP 
subunit-epitope, that normally labels only a single band 
between 20.1 and 30 kDa, it may represent an inverted 
homodimer of two a-subunits such that they can expose the 
normally hidden a-subunit-epitope. This form is certainly 
not the intact cup-heterodimer, since it could neither be 
stained with holo-hormone specific c-MCA nor with fl-MCA. 
The diagnostic and clinical relevance of this molecule remains 
to be elucidated. 
Since both normal pregnancy- and tumor-derived variants 
of hCG with abnormal highly negative carbohydrate-asso- 
ciated surface charges and variants lacking this charge were 
detectable with each of our MCA, it is obvious that carbo- 
hydrate moieties play no significant role in the immunolog- 
ical make-up of hCG. Sugar antennae, even highly branched 
and oversized ones, apparently do not mask epitopes, and 
acidic oligosaccharides do not exert electrostatic repulsive 
forces DS. antibodies, preventing their binding to the respec- 
tive epitopes. Thus, epitopes of hCG seem to be predomi- 
nantly shaped by the protein backbone. Glycosylation ap- 
pears to have little influence on single epitopes whereas it is 
a crucial factor for the biological activity of hCG (2, 17). 
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These data support the diagnostic specificity, sensitivity, 
and accuracy of currently employed immunoassays for hCG 
as long as they can detect holo-hCG and free hCGP. Em- 
ploying any specific MCA for accessible epitopes of hCG/3 
would be appropriate for the accuracy of such immunoas- 
says. The likelihood of a false negative result for pregnancy 
or hCG-secreting tumors seems to be small except for cases 
when free a-subunit is secreted exclusively (5, 8, 25). 
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